Reprogramming.
Hematopoiesis.
Immunity.

Lab

We are studying how hematopoietic cell fate is specified, maintained, and eventually modified or reversed. Inspired from the fields of stem cell biology, immunology, and cancer we use an interdisciplinary approach to mechanistically understand hematopoietic and immune cell identities and translate our findings into novel gene and cell therapies.

Research

Merging Stem Cells with Immunology by Cell Fate Reprogramming. Learn more about our research lines:

Latest Publications

Ontogenic Shifts in Cellular Fate Are Linked to Proteotype Changes in Lineage-biased Hematopoietic Progenitor Cells

Maria Jassinskaja, Kristýna Pimková, Nejc Arh, Emil Johansson, Mina Davoudi, Carlos-Filipe Pereira, Ewa Sitnicka, Jenny Hansson

March 23, 2021 / Volume 34, Issue 23
Cell Reports

Harnessing the Potential of Cell Fate Reprogramming for Cancer Immunotherapy

Ervin Ascic

March 17, 2021
MSc. Thesis - University of Vienna

Team

We are a diverse group – molecular biologists, MDs, PharmDs, tumor immunologists, stem cell biologists and computational scientists – at all career stages. We architect strategies to dissect and manipulate immune cell identity.

Looking for an opportunity? Join our international team!

Latest News

Filipe Pereira Is The New Editor-in-Chief of Cellular Reprogramming

Following on the legacy of Professor Sir Ian Wilmut, Filipe Pereira becomes the new Editor-in-Chief of the Cellular Reprogramming Journal.

Filipe Pereira Awarded a Swedish Research Council Consolidator Grant

The Swedish Research Council (Vetenskapsrådet) has published the results for this year’s applications for consolidator grants, in which Filipe Pereira was selected for, in the scientific area of Medicine and health.

Luís Oliveira Awarded a PhD Studentship From The Foundation for Science and Technology

Pereira Lab researcher Luís Oliveira was awarded a fully funded 4 year scholarship by the Portuguese Foundation for Science and Technology (FCT) to develop his PhD-leading research.